CNN2P11

Across TCGA pan-cancer cohorts, CNN2P11 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated CNN2P11 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher CNN2P11 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CNN2P11 expression acts as an unfavorable survival marker.

LIHC, KICH, and STAD are the cancer types where CNN2P11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.047	0.779	<.001	144	view →
KICH	DFS	Tertile	All	0.043	0.971	<.001	54	view →
STAD	DFS	Tertile	III,IV	0.216	0.508	.010	51	view →
KIRC	DFS	Tertile	IV	0.241	0.618	.006	48	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
KIRP	OS	Tertile	All	0.760	0.921	.001	24	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CNN2P11–LIHC (OS)

Open the LIHC breakdown →